GeneLink Subsidiary GeneWize Hosts First Annual Science Summit Featuring Presentations and Appearances by World Renowned Experts

Press Release Source: GeneLink, Inc. GeneLink Subsidiary GeneWize Hosts First Annual Science Summit Featuring Presentations and Appearances by World Renowned Experts GeneWize Announces Fall Launch of Genetically Customized Age Defying, Youth Activating Super Serum™ - Available in Advance to the First 250 Registrants for the August Marketing Event On Thursday June 4, 2009, 3:42 pm EDT ORLANDO, Fla.--()--GeneLink, Inc. (OTCBB:GNLK.OB), “the Company,” or “GeneLink”, a lead
Read article...

GeneWize Hires Senior Vice-President of Sales and Marketing: GeneLink's GeneWize Subsidiary Prepares for Growth

Press Release Source: GeneLink, Inc. GeneWize Hires Senior Vice-President of Sales and Marketing: GeneLink's GeneWize Subsidiary Prepares for Growth On Tuesday May 26, 2009, 9:45 am EDT ORLANDO, Fla.--()--GeneLink, Inc. (OTCBB:GNLK.OB), a leading consumer genomics biotech company, recently announced the appointment of Sharon M. Tahaney to the position of Senior Vice-President of Sales and Marketing of GeneWize Life Sciences, Inc. Ms. Tahaney comes from a
Read article...

GeneLink Reports First Quarter Results Revenues Approximately $2.0M

Read article...

Lawsuit by Former Officer Dismissed; GeneLink and GeneWize Poised for Growth

Press Release Source: GeneLink, Inc. Lawsuit by Former Officer Dismissed; GeneLink and GeneWize Poised for Growth On Wednesday May 13, 2009, 8:30 am EDT ORLANDO, Fla.--()--GeneLink, Inc. (OTCBB: GNLK.OB), a leading consumer genomics biotech company, is pleased to report that the Philadelphia Court of Common Pleas has dismissed the lawsuit brought by the Company’s former CEO and President, John DePhillipo, and his wife against the Company, its subsidiary GeneWize Life Sciences, Inc. (“GeneWize”), and several of the Company’s officers, directors and advisors. The
Read article...

GeneLink Receives Financing

(OTCBB:GNLK) GeneLink, Inc. Press ReleaseSource: GeneLink, Inc. GeneLink Receives FinancingWednesday March 4, 9:30 am ET Raises over $2.4M New Products and Programs Launch in Q1 2009 ORLANDO, Fla.-GeneLink, Inc. , , a leading consumer genomics biotech company, recently reported that it has closed two separate private placements for gross proceeds of $2,418,500. The first private placement closed in January 2009 and the Company received initial funding on the second private placement on February 27, 2009. Monte Taylor, GeneLink?s CEO, stated, ?In view of difficult conditions in the financial markets, we are extremely pleased with the financial recognition GeneLink has rece
Read article...

GeneLink Announces Strategic Expansion of Testing Capabilities through Service Agreement with Nationally Recognized Genetic Testing Laboratory

(OTCBB:GNLK) GeneLink, Inc. Press ReleaseSource: GeneLink Biosciences, Inc. GeneLink Announces Strategic Expansion of Testing Capabilities through Service Agreement with Nationally Recognized Genetic Testing LaboratoryThursday November 20, 3:14 pm ET ORLANDO, Fla.-GeneLink Biosciences, Inc. , a leading consumer genomics biotech company, recently announced that it has expanded its testing capabilities through a service agreement with a nationally recognized diagnostic laboratory to process GeneLink?s SNP-based (single nucleotide polymorphism) assessments GeneLink?s DNA assessments are based on GeneLink?s scientific research and patents and utilize GeneLink?s patented DNA Collection Kit®. Bernard L. Kasten, M.D., GeneLink?s Executive Chairman, stated, ?The highly successful launch
Read article...

GeneLink Reports Record Third Quarter Results, Revenues Exceed $1.8M

(OTCBB:GNLK) GeneLink, Inc. Press ReleaseSource: GeneLink, Inc. GeneLink Reports Record Third Quarter Results, Revenues Exceed $1.8MMonday November 17, 9:05 am ET GeneWize August Launch Propels Company Forward ORLANDO, Fla.-GeneLink, Inc. , a leading consumer genomics biotech company, recently reported financial results for the fiscal 2008 three and nine-month periods ended September 30, 2008.Financial Highlights: Quarterly net sales of over $1.8 million compared to $26,150 in the same period in fiscal 2007 Quarterly gross profit of over $1.4 million compared to $14,542 for the same period in fiscal 2007 Deferred Revenue of over $2.6 million
Read article...